Clinical trial · Observational
Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma
NCT02613312CI-TRIAL-00079242terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Practice change in what is considered standard of care
Summary
Brief summary (as posted)
The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mesothelioma | Malignant Mesothelioma | CURATED_EXACT | 0.92 |
| Solitary Fibrous Tumor of the Pleura | Pleural Solitary Fibrous Tumor | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Overall Survival (OS)
- timeFrame
- 2 years
- description
- OS is defined as the length of time from study enrollment to death by any cause. Survival status of patients will be monitored every 6 months
Secondary outcomes (1)
- measure
- Progression free survival (PFS) as evidenced by CT scan review
- timeFrame
- 2 years
- description
- PFS is defined as the length of time from study enrollment to the time of disease progression.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Subject provides informed consent * Subject is \>18 years of age * Subject is deemed competent for making medical decisions * Subject is scheduled to undergo chemotherapy followed by surgery and then IMRT * Subject is a surgical candidate * A negative pregnancy test is required in women of child-bearing potential, as standard of care. Exclusion Criteria: •Subject is \<18 years old.
References
Publications (0)
Data not yet available
No reference posted for this study.